• Mashup Score: 4

    Pamela Torres used to run a seven-minute mile. But when the former track star suffered a severe knee injury in college, she began to rapidly gain weight. She was diagnosed with type 2 diabetes in her 30s and obesity in her early 50s. Torres, now age 68, was prescribed Ozempic, a medication approved to treat type 2 diabetes, in January. She lost nearly 20 percent of her body weight. Her joints didn’t ache as much, and her blood sugar returned to healthy levels. “I bought three new pairs of jeans.

    Tweet Tweets with this article
    • Should insurance cover Ozempic and Wegovy? Absolutely yes! In fact this year in #Connecticut we passed a bill that mandates that #Medicaid cover both bariatric surgery and #Obesity medications… but this LAW has yet to be enforced by the state. 1/ https://t.co/mLnTGPQwxZ

  • Mashup Score: 0

    Investigators may have uncovered the impact of the 2014 and 2015 Medicaid expansion on cancer clinical trial participation, according to a recent study published by Unger et al in JAMA Oncology. The new findings suggested that Medicaid expansion under the Patient Protection and Affordable Care Act may have resulted in a 19% annual increase in Medicaid-insured patient participation in publicly funded cancer clinical trials. “An individual’s type of insurance can be a strong indicator of their socioeconomic

    Tweet Tweets with this article
    • Medicaid Expansion and Participation in Cancer Clinical Trials Among Patients Insured by Medicaid https://t.co/tVhvKKhde2 #cancer #clinicaltrials #Medicaid